Emil Ramsø Kyvsgaard
4PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 11, 2026
A real-world comparison of CD20xCD3 bispecific antibodies versus chemotherapy regimens in 3+ line relapsed/refractory diffuse large B cell lymphoma.Emil Ramsø Kyvsgaard, Alexander Djupnes Fuglkjær, Ahmed Ludvigsen Al-Mashhadi
|Jan 07, 2026
Impact of prior bendamustine exposure on bispecific antibody outcomes in relapsed/refractory follicular lymphoma.Gloria Iacoboni, Emil Ramsø Kyvsgaard, Víctor Navarro Garcés
|Jan 26, 2025
NOTCH1 Mutations Are Associated With Therapy-Resistance in Patients With B-Cell Lymphoma Treated With CD20xCD3 Bispecific Antibodies.Emil R Kyvsgaard, Morten Grauslund, Lene Sjø
|Oct 13, 2023
Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy.Emil R Kyvsgaard, Caroline Riley, Michael Roost Clausen
Pageof 1
Frequent Collaborators
3 joint publications
Simon Husby
2 joint publications
Carsten Utoft Niemann
1 joint publications
Gloria Iacoboni
1 joint publications
Víctor Navarro
1 joint publications
David A Russler-Germain
1 joint publications
Katharine Louise Lewis
1 joint publications
Alejandro Martin Garcia-Sancho
1 joint publications
Itziar Carro
1 joint publications
Michael Roost Clausen
1 joint publications
Dylan Therwhanger
